Medindia LOGIN REGISTER
Medindia

Drug Safety Labeling Changes - July 2016

Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side- effects, adverse reactions, contra-indications and precautions necessary for a drug. This information is important for safe practice of medicine.

Key to Label Sections

  • C - Contraindications
  • W - Warnings
  • P - Precautions
  • AR - Adverse Reactions
Drug Name Sections Modified
C W P AR
Ado-trastuzumab Emtansine
Apixaban
Brimonidine
Canakinumab
Clofazimine
Evolocumab
Exemestane
Fluorouracil
Fulvestrant
Levofloxacin
Nitazoxanide
Norfloxacin
Pramipexole
Prasugrel
Pravastatin Sodium
Ticagrelor
Trabectedin
Vandetanib

2016 - Monthly Summary Report for Drug Label Changes

2015 - Monthly Summary Report for Drug Label Changes

2014 - Monthly Summary Report for Drug Label Changes

2013 - Monthly Summary Report for Drug Label Changes

2012 - Monthly Summary Report for Drug Label Changes

Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Ultimate Weight Loss Handbook: A Complete Guide to Achieving Your Goals
Stay Connected
Available on the Android Market Available on the App Store